LUMOS DIAGNOSTICS HOLDINGS LIMITED - Announcements

1.37%

7.2¢

Market Cap $54.64M

Healthcare Medical Instruments & Supplies

Lumos Diagnostics Holdings Limited is an Australia-based company specializes in... Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. It manages the full development program for POC assays.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	21/07/25	521.46KB	Share
LDX	Lumos Signs Binding Term Sheet for A$5M Loan Facility	PRICE SENSITIVE	17/07/25	265.34KB	Share
LDX	Reinstatement to Quotation	PRICE SENSITIVE	16/07/25	116.19KB	Share
LDX	Lumos Signs Pivotal US FebriDx Agreement	PRICE SENSITIVE	16/07/25	274.53KB	Share
LDX	Suspension from Quotation	PRICE SENSITIVE	15/07/25	252.07KB	Share
LDX	Trading Halt	PRICE SENSITIVE	11/07/25	261.28KB	Share
LDX	Pause in Trading	PRICE SENSITIVE	11/07/25	113.46KB	Share
LDX	Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone	PRICE SENSITIVE	18/06/25	253.79KB	Share
LDX	Lumos Reaches Recruitment Milestone in FebriDx Study	PRICE SENSITIVE	02/06/25	253.61KB	Share
LDX	Lumos Secures Sixth US Medicare Reimbursement for FebriDx	PRICE SENSITIVE	27/05/25	308.44KB	Share
LDX	Lumos Secures Fifth US Medicare Reimbursement for FebriDx	PRICE SENSITIVE	19/05/25	309.53KB	Share
LDX	Lumos Advances FebriDx Sales with iMedical Purchase Order	PRICE SENSITIVE	14/05/25	221.67KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/25	355.68KB	Share
LDX	Lumos Secures Further US Medicare Reimbursement for FebriDx	PRICE SENSITIVE	23/04/25	418.31KB	Share
LDX	Lumos Secures Key US Reimbursement Milestones for FebriDx	PRICE SENSITIVE	17/04/25	398.63KB	Share
LDX	Hologic Development Agreement Expanded Scope of Works	PRICE SENSITIVE	03/03/25	250.29KB	Share
LDX	Appendix 4D and Half Year Report	PRICE SENSITIVE	27/02/25	672.2KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	428.29KB	Share
LDX	Commencement of FebriDx CLIA Waiver Study	PRICE SENSITIVE	19/12/24	341.9KB	Share
LDX	Lumos receives CPT PLA Code for FebriDX in the US	PRICE SENSITIVE	05/12/24	255.17KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/24	525.45KB	Share
LDX	Lumos Successfully Completes Retail Entitlement Offer	PRICE SENSITIVE	08/10/24	202.82KB	Share
LDX	Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study	PRICE SENSITIVE	03/10/24	287.36KB	Share
LDX	Lumos Awarded National Contract with MediGroup for FebriDx	PRICE SENSITIVE	25/09/24	264.86KB	Share
LDX	Lumos Achieves First Phase 2 Milestone in Hologic Agreement	PRICE SENSITIVE	20/09/24	231.79KB	Share
LDX	Lumos Appoints Thermo Fisher Scientific as US Distributor	PRICE SENSITIVE	16/09/24	171.99KB	Share
LDX	Retail Entitlement Offer Booklet	PRICE SENSITIVE	11/09/24	17.57MB	Share
LDX	Lumos Successfully Completes Institutional Entitlement Offer	PRICE SENSITIVE	06/09/24	233.76KB	Share
LDX	Investor Presentation	PRICE SENSITIVE	04/09/24	16.98MB	Share
LDX	Lumos Announces $10m Equity Raising and Welcomes Tenmile	PRICE SENSITIVE	04/09/24	296.14KB	Share
LDX	Trading Halt	PRICE SENSITIVE	04/09/24	606.67KB	Share
LDX	Lumos Announces Intention to Undertake Entitlement Offer	PRICE SENSITIVE	03/09/24	302.75KB	Share
LDX	FY24 Full Year Results Announcement	PRICE SENSITIVE	27/08/24	279.07KB	Share
LDX	FY24 Appendix 4E	PRICE SENSITIVE	27/08/24	198.04KB	Share
LDX	Lumos and BDI Progress New Point of Care Test	PRICE SENSITIVE	26/08/24	305.59KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	499.44KB	Share
LDX	Lumos Expands Henry Schein FebriDx Distribution Partnership	PRICE SENSITIVE	09/07/24	257.31KB	Share
LDX	Lumos Expands Distribution for FebriDx in AUS and NZ	PRICE SENSITIVE	04/07/24	400.09KB	Share
LDX	Lumos Receives Second US$5 million Hologic IP Payment	PRICE SENSITIVE	04/06/24	233.62KB	Share
LDX	Lumos Achieves Key Phase 1 Milestone in Hologic Agreement	PRICE SENSITIVE	06/05/24	284.14KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/04/24	512.47KB	Share
LDX	Half Year Results Investor Presentation	PRICE SENSITIVE	28/02/24	3.43MB	Share
LDX	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/24	667.5KB	Share
LDX	Lumos Appoints Henry Schein as US Distributor for FebriDx	PRICE SENSITIVE	12/02/24	265.17KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	548KB	Share
LDX	Lumos Signs Major Development and IP Agreements with Hologic	PRICE SENSITIVE	11/01/24	225.4KB	Share
LDX	Commercial Operations Update Webinar Presentation	PRICE SENSITIVE	06/12/23	18.93MB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	476.55KB	Share
LDX	LDX Raises A$2.65 Million in Successful Placement	PRICE SENSITIVE	30/10/23	193.13KB	Share
LDX	FDA Grants EUA for ViraDx	PRICE SENSITIVE	11/09/23	268.34KB	Share
LDX	FY23 Full Year Results Investor Presentation	PRICE SENSITIVE	30/08/23	2.63MB	Share
LDX	FY23 Full Year Results Announcement	PRICE SENSITIVE	30/08/23	326.5KB	Share
LDX	FY23 Appendix 4E	PRICE SENSITIVE	30/08/23	77.66KB	Share
LDX	Henry Schein Expands Distribution Partnership for FebriDx	PRICE SENSITIVE	16/08/23	334.47KB	Share
LDX	Core Camera Reader Patent Granted in Europe and Japan	PRICE SENSITIVE	16/08/23	238.23KB	Share
LDX	Completion of Early Redemption of Convertible Notes	PRICE SENSITIVE	10/08/23	183.55KB	Share
LDX	Lumos Receives Research & Development Tax Rebate	PRICE SENSITIVE	10/08/23	213.88KB	Share
LDX	Capital Raise Result and Issue of Early Redemption Notices	PRICE SENSITIVE	03/08/23	230.22KB	Share
LDX	Lumos Secures Feasibility Project with BDI	PRICE SENSITIVE	27/07/23	184.08KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	20/07/23	440.24KB	Share
LDX	Henry Schein Expands Distribution Partnership For FebriDx	PRICE SENSITIVE	18/07/23	199.26KB	Share
LDX	Investor Presentation	PRICE SENSITIVE	10/07/23	3.46MB	Share
LDX	Lumos completes $4.75m Placement and launches SPP	PRICE SENSITIVE	10/07/23	330.15KB	Share
LDX	Trading Halt	PRICE SENSITIVE	06/07/23	231.61KB	Share
LDX	Lumos Receives US FDA Clearance for FebriDx	PRICE SENSITIVE	03/07/23	245KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	435.08KB	Share
LDX	Lumos signs three new agreements with Hologic	PRICE SENSITIVE	16/03/23	235.2KB	Share
LDX	Lumos Diagnostics FY23 First Half Year Results	PRICE SENSITIVE	27/02/23	251.87KB	Share
LDX	Appendix 4D and Half Year Report	PRICE SENSITIVE	27/02/23	771.09KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/23	501.46KB	Share
LDX	Lumos Secures Two Service Agreements With Hologic	PRICE SENSITIVE	23/11/22	234.24KB	Share
LDX	LDX signs agreement to raise $8m & announces General Meeting	PRICE SENSITIVE	21/11/22	272.03KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	502.67KB	Share
LDX	Publication of Data from DISRUPT Clinical Trial in JAMA	PRICE SENSITIVE	19/10/22	238.31KB	Share
LDX	Lumos Completes Closure of Sarasota Facility	PRICE SENSITIVE	03/10/22	235.77KB	Share
LDX	Outcome of Appeal to FDA for FebriDx	PRICE SENSITIVE	03/10/22	237.19KB	Share
LDX	FY22 Full Year Results Investor Presentation	PRICE SENSITIVE	26/08/22	7.09MB	Share
LDX	FY22 Full Year Results Media Release	PRICE SENSITIVE	26/08/22	349.48KB	Share
LDX	FY22 Annual Report	PRICE SENSITIVE	26/08/22	10.36MB	Share
LDX	FY22 Appendix 4E	PRICE SENSITIVE	26/08/22	55.85KB	Share
LDX	Lumos Pilot Manufacturing to Commence in Carlsbad	PRICE SENSITIVE	23/08/22	222.78KB	Share
LDX	Lumos Withdraws from Local Manufacturing Proposal	PRICE SENSITIVE	08/08/22	176.95KB	Share
LDX	Lumos Files Appeal To The FDA For FebriDx	PRICE SENSITIVE	08/08/22	179.8KB	Share
LDX	Lumos To Close Sarasota Facility	PRICE SENSITIVE	02/08/22	182.17KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	332.02KB	Share
LDX	Reinstatement to Official Quotation	PRICE SENSITIVE	11/07/22	86.28KB	Share
LDX	FDA Decision for FebriDx	PRICE SENSITIVE	11/07/22	181.64KB	Share
LDX	Voluntary Suspension	PRICE SENSITIVE	08/07/22	318.68KB	Share
LDX	Trading Halt	PRICE SENSITIVE	06/07/22	314.22KB	Share
LDX	Security Class Reinstatement of Quotation LDXO	PRICE SENSITIVE	01/07/22	86.43KB	Share
LDX	ViraDx Receives Interim Order Authorisation in Canada	PRICE SENSITIVE	27/06/22	312.14KB	Share
LDX	Security Class Suspension from Quotation LDXO	PRICE SENSITIVE	24/06/22	142.5KB	Share
LDX	Lumos secures initial development services contract	PRICE SENSITIVE	17/06/22	191.54KB	Share
LDX	Successful Completion of Institutional Entitlement Offer	PRICE SENSITIVE	08/06/22	190.51KB	Share
LDX	Prospectus	PRICE SENSITIVE	06/06/22	1MB	Share
LDX	Target Market Determination	PRICE SENSITIVE	06/06/22	158.29KB	Share
LDX	Investor Presentation	PRICE SENSITIVE	06/06/22	1.44MB	Share
LDX	Operational Update and Accelerated Entitlement Offer	PRICE SENSITIVE	06/06/22	322.66KB	Share
LDX	Trading Halt	PRICE SENSITIVE	02/06/22	320.21KB	Share
LDX	Pause in Trading	PRICE SENSITIVE	02/06/22	116.17KB	Share

LDX Quarterly Activities/Appendix 4C Cash Flow Report
21/07/25	PRICE SENSITIVE	521.46KB	Share
LDX Lumos Signs Binding Term Sheet for A$5M Loan Facility
17/07/25	PRICE SENSITIVE	265.34KB	Share
LDX Reinstatement to Quotation
16/07/25	PRICE SENSITIVE	116.19KB	Share
LDX Lumos Signs Pivotal US FebriDx Agreement
16/07/25	PRICE SENSITIVE	274.53KB	Share
LDX Suspension from Quotation
15/07/25	PRICE SENSITIVE	252.07KB	Share
LDX Trading Halt
11/07/25	PRICE SENSITIVE	261.28KB	Share
LDX Pause in Trading
11/07/25	PRICE SENSITIVE	113.46KB	Share
LDX Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone
18/06/25	PRICE SENSITIVE	253.79KB	Share
LDX Lumos Reaches Recruitment Milestone in FebriDx Study
02/06/25	PRICE SENSITIVE	253.61KB	Share
LDX Lumos Secures Sixth US Medicare Reimbursement for FebriDx
27/05/25	PRICE SENSITIVE	308.44KB	Share
LDX Lumos Secures Fifth US Medicare Reimbursement for FebriDx
19/05/25	PRICE SENSITIVE	309.53KB	Share
LDX Lumos Advances FebriDx Sales with iMedical Purchase Order
14/05/25	PRICE SENSITIVE	221.67KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25	PRICE SENSITIVE	355.68KB	Share
LDX Lumos Secures Further US Medicare Reimbursement for FebriDx
23/04/25	PRICE SENSITIVE	418.31KB	Share
LDX Lumos Secures Key US Reimbursement Milestones for FebriDx
17/04/25	PRICE SENSITIVE	398.63KB	Share
LDX Hologic Development Agreement Expanded Scope of Works
03/03/25	PRICE SENSITIVE	250.29KB	Share
LDX Appendix 4D and Half Year Report
27/02/25	PRICE SENSITIVE	672.2KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	428.29KB	Share
LDX Commencement of FebriDx CLIA Waiver Study
19/12/24	PRICE SENSITIVE	341.9KB	Share
LDX Lumos receives CPT PLA Code for FebriDX in the US
05/12/24	PRICE SENSITIVE	255.17KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
29/10/24	PRICE SENSITIVE	525.45KB	Share
LDX Lumos Successfully Completes Retail Entitlement Offer
08/10/24	PRICE SENSITIVE	202.82KB	Share
LDX Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study
03/10/24	PRICE SENSITIVE	287.36KB	Share
LDX Lumos Awarded National Contract with MediGroup for FebriDx
25/09/24	PRICE SENSITIVE	264.86KB	Share
LDX Lumos Achieves First Phase 2 Milestone in Hologic Agreement
20/09/24	PRICE SENSITIVE	231.79KB	Share
LDX Lumos Appoints Thermo Fisher Scientific as US Distributor
16/09/24	PRICE SENSITIVE	171.99KB	Share
LDX Retail Entitlement Offer Booklet
11/09/24	PRICE SENSITIVE	17.57MB	Share
LDX Lumos Successfully Completes Institutional Entitlement Offer
06/09/24	PRICE SENSITIVE	233.76KB	Share
LDX Investor Presentation
04/09/24	PRICE SENSITIVE	16.98MB	Share
LDX Lumos Announces $10m Equity Raising and Welcomes Tenmile
04/09/24	PRICE SENSITIVE	296.14KB	Share
LDX Trading Halt
04/09/24	PRICE SENSITIVE	606.67KB	Share
LDX Lumos Announces Intention to Undertake Entitlement Offer
03/09/24	PRICE SENSITIVE	302.75KB	Share
LDX FY24 Full Year Results Announcement
27/08/24	PRICE SENSITIVE	279.07KB	Share
LDX FY24 Appendix 4E
27/08/24	PRICE SENSITIVE	198.04KB	Share
LDX Lumos and BDI Progress New Point of Care Test
26/08/24	PRICE SENSITIVE	305.59KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	499.44KB	Share
LDX Lumos Expands Henry Schein FebriDx Distribution Partnership
09/07/24	PRICE SENSITIVE	257.31KB	Share
LDX Lumos Expands Distribution for FebriDx in AUS and NZ
04/07/24	PRICE SENSITIVE	400.09KB	Share
LDX Lumos Receives Second US$5 million Hologic IP Payment
04/06/24	PRICE SENSITIVE	233.62KB	Share
LDX Lumos Achieves Key Phase 1 Milestone in Hologic Agreement
06/05/24	PRICE SENSITIVE	284.14KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
23/04/24	PRICE SENSITIVE	512.47KB	Share
LDX Half Year Results Investor Presentation
28/02/24	PRICE SENSITIVE	3.43MB	Share
LDX Appendix 4D and Half Year Report
28/02/24	PRICE SENSITIVE	667.5KB	Share
LDX Lumos Appoints Henry Schein as US Distributor for FebriDx
12/02/24	PRICE SENSITIVE	265.17KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	548KB	Share
LDX Lumos Signs Major Development and IP Agreements with Hologic
11/01/24	PRICE SENSITIVE	225.4KB	Share
LDX Commercial Operations Update Webinar Presentation
06/12/23	PRICE SENSITIVE	18.93MB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	476.55KB	Share
LDX LDX Raises A$2.65 Million in Successful Placement
30/10/23	PRICE SENSITIVE	193.13KB	Share
LDX FDA Grants EUA for ViraDx
11/09/23	PRICE SENSITIVE	268.34KB	Share
LDX FY23 Full Year Results Investor Presentation
30/08/23	PRICE SENSITIVE	2.63MB	Share
LDX FY23 Full Year Results Announcement
30/08/23	PRICE SENSITIVE	326.5KB	Share
LDX FY23 Appendix 4E
30/08/23	PRICE SENSITIVE	77.66KB	Share
LDX Henry Schein Expands Distribution Partnership for FebriDx
16/08/23	PRICE SENSITIVE	334.47KB	Share
LDX Core Camera Reader Patent Granted in Europe and Japan
16/08/23	PRICE SENSITIVE	238.23KB	Share
LDX Completion of Early Redemption of Convertible Notes
10/08/23	PRICE SENSITIVE	183.55KB	Share
LDX Lumos Receives Research & Development Tax Rebate
10/08/23	PRICE SENSITIVE	213.88KB	Share
LDX Capital Raise Result and Issue of Early Redemption Notices
03/08/23	PRICE SENSITIVE	230.22KB	Share
LDX Lumos Secures Feasibility Project with BDI
27/07/23	PRICE SENSITIVE	184.08KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
20/07/23	PRICE SENSITIVE	440.24KB	Share
LDX Henry Schein Expands Distribution Partnership For FebriDx
18/07/23	PRICE SENSITIVE	199.26KB	Share
LDX Investor Presentation
10/07/23	PRICE SENSITIVE	3.46MB	Share
LDX Lumos completes $4.75m Placement and launches SPP
10/07/23	PRICE SENSITIVE	330.15KB	Share
LDX Trading Halt
06/07/23	PRICE SENSITIVE	231.61KB	Share
LDX Lumos Receives US FDA Clearance for FebriDx
03/07/23	PRICE SENSITIVE	245KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	435.08KB	Share
LDX Lumos signs three new agreements with Hologic
16/03/23	PRICE SENSITIVE	235.2KB	Share
LDX Lumos Diagnostics FY23 First Half Year Results
27/02/23	PRICE SENSITIVE	251.87KB	Share
LDX Appendix 4D and Half Year Report
27/02/23	PRICE SENSITIVE	771.09KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23	PRICE SENSITIVE	501.46KB	Share
LDX Lumos Secures Two Service Agreements With Hologic
23/11/22	PRICE SENSITIVE	234.24KB	Share
LDX LDX signs agreement to raise $8m & announces General Meeting
21/11/22	PRICE SENSITIVE	272.03KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	502.67KB	Share
LDX Publication of Data from DISRUPT Clinical Trial in JAMA
19/10/22	PRICE SENSITIVE	238.31KB	Share
LDX Lumos Completes Closure of Sarasota Facility
03/10/22	PRICE SENSITIVE	235.77KB	Share
LDX Outcome of Appeal to FDA for FebriDx
03/10/22	PRICE SENSITIVE	237.19KB	Share
LDX FY22 Full Year Results Investor Presentation
26/08/22	PRICE SENSITIVE	7.09MB	Share
LDX FY22 Full Year Results Media Release
26/08/22	PRICE SENSITIVE	349.48KB	Share
LDX FY22 Annual Report
26/08/22	PRICE SENSITIVE	10.36MB	Share
LDX FY22 Appendix 4E
26/08/22	PRICE SENSITIVE	55.85KB	Share
LDX Lumos Pilot Manufacturing to Commence in Carlsbad
23/08/22	PRICE SENSITIVE	222.78KB	Share
LDX Lumos Withdraws from Local Manufacturing Proposal
08/08/22	PRICE SENSITIVE	176.95KB	Share
LDX Lumos Files Appeal To The FDA For FebriDx
08/08/22	PRICE SENSITIVE	179.8KB	Share
LDX Lumos To Close Sarasota Facility
02/08/22	PRICE SENSITIVE	182.17KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	332.02KB	Share
LDX Reinstatement to Official Quotation
11/07/22	PRICE SENSITIVE	86.28KB	Share
LDX FDA Decision for FebriDx
11/07/22	PRICE SENSITIVE	181.64KB	Share
LDX Voluntary Suspension
08/07/22	PRICE SENSITIVE	318.68KB	Share
LDX Trading Halt
06/07/22	PRICE SENSITIVE	314.22KB	Share
LDX Security Class Reinstatement of Quotation LDXO
01/07/22	PRICE SENSITIVE	86.43KB	Share
LDX ViraDx Receives Interim Order Authorisation in Canada
27/06/22	PRICE SENSITIVE	312.14KB	Share
LDX Security Class Suspension from Quotation LDXO
24/06/22	PRICE SENSITIVE	142.5KB	Share
LDX Lumos secures initial development services contract
17/06/22	PRICE SENSITIVE	191.54KB	Share
LDX Successful Completion of Institutional Entitlement Offer
08/06/22	PRICE SENSITIVE	190.51KB	Share
LDX Prospectus
06/06/22	PRICE SENSITIVE	1MB	Share
LDX Target Market Determination
06/06/22	PRICE SENSITIVE	158.29KB	Share
LDX Investor Presentation
06/06/22	PRICE SENSITIVE	1.44MB	Share
LDX Operational Update and Accelerated Entitlement Offer
06/06/22	PRICE SENSITIVE	322.66KB	Share
LDX Trading Halt
02/06/22	PRICE SENSITIVE	320.21KB	Share
LDX Pause in Trading
02/06/22	PRICE SENSITIVE	116.17KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 7.2¢		Change -0.001(1.37%)		Mkt cap ! $54.64M

Open	High	Low	Value	Volume
7.3¢	7.4¢	7.2¢	$258.7K	3.536M

Buyers (Bids)

No.	Vol.	Price($)
3	204867	7.2¢

Sellers (Offers)

Price($)	Vol.	No.
7.3¢	333000	1

View Market Depth

No.	Vol.	Price($)
3	262621	0.072
6	924651	0.071
5	649000	0.070
6	497479	0.069
6	2108000	0.068

Price($)	Vol.	No.
0.073	333000	1
0.074	156989	3
0.075	1384845	4
0.076	401691	8
0.077	331000	5

Last trade - 12.11pm 31/07/2025 (20 minute delay)


Last 7.2¢		Change -0.001 ( 2.70 %)
Open	High	Low	Volume
7.1¢	7.4¢	7.1¢	510660
Last updated 12.11pm 31/07/2025 ?

LDX (ASX) Chart

LUMOS DIAGNOSTICS HOLDINGS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available